Literature DB >> 17558400

Regulation of T-type calcium channels by Rho-associated kinase.

Mircea Iftinca1, Jawed Hamid, Lina Chen, Diego Varela, Reza Tadayonnejad, Christophe Altier, Ray W Turner, Gerald W Zamponi.   

Abstract

We investigated the regulation of T-type channels by Rho-associated kinase (ROCK). Activation of ROCK via the endogenous ligand lysophosphatidic acid (LPA) reversibly inhibited the peak current amplitudes of rat Ca(v)3.1 and Ca(v)3.3 channels without affecting the voltage dependence of activation or inactivation, whereas Ca(v)3.2 currents showed depolarizing shifts in these parameters. LPA-induced inhibition of Ca(v)3.1 was dependent on intracellular GTP, and was antagonized by treatment with ROCK and RhoA inhibitors, LPA receptor antagonists or GDPssS. Site-directed mutagenesis of the Ca(v)3.1 alpha1 subunit revealed that the ROCK-mediated effects involve two distinct phosphorylation consensus sites in the domain II-III linker. ROCK activation by LPA reduced native T-type currents in Y79 retinoblastoma and in lateral habenular neurons, and upregulated native Ca(v)3.2 current in dorsal root ganglion neurons. Our data suggest that ROCK is an important regulator of T-type calcium channels, with potentially far-reaching implications for multiple cell functions modulated by LPA.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17558400     DOI: 10.1038/nn1921

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN: 1097-6256            Impact factor:   24.884


  25 in total

1.  Mice mechanoreceptors are modulated by Ca(v)3.2 T-type calcium channels.

Authors:  Rodrigo Bolaños-Jiménez; César Escamilla-Ocañas; Héctor Martínez-Menchaca; Gerardo Rivera-Silva
Journal:  J Physiol       Date:  2012-01-01       Impact factor: 5.182

Review 2.  T-type calcium channels and vascular function: the new kid on the block?

Authors:  Ivana Y-T Kuo; Stephanie E Wölfle; Caryl E Hill
Journal:  J Physiol       Date:  2010-12-20       Impact factor: 5.182

Review 3.  T-type voltage-gated calcium channels as targets for the development of novel pain therapies.

Authors:  Slobodan M Todorovic; Vesna Jevtovic-Todorovic
Journal:  Br J Pharmacol       Date:  2011-06       Impact factor: 8.739

4.  Minimal alterations in T-type calcium channel gating markedly modify physiological firing dynamics.

Authors:  A Tscherter; F David; T Ivanova; C Deleuze; J J Renger; V N Uebele; H-S Shin; T Bal; N Leresche; R C Lambert
Journal:  J Physiol       Date:  2011-02-14       Impact factor: 5.182

Review 5.  T-type calcium channel blockers as neuroprotective agents.

Authors:  Benjamin J Kopecky; Ruqiang Liang; Jianxin Bao
Journal:  Pflugers Arch       Date:  2014-02-25       Impact factor: 3.657

Review 6.  Role of T-type channels in vasomotor function: team player or chameleon?

Authors:  Ivana Y-T Kuo; Lauren Howitt; Shaun L Sandow; Alexandra McFarlane; Pernille B Hansen; Caryl E Hill
Journal:  Pflugers Arch       Date:  2014-01-31       Impact factor: 3.657

Review 7.  Insights into autotaxin: how to produce and present a lipid mediator.

Authors:  Wouter H Moolenaar; Anastassis Perrakis
Journal:  Nat Rev Mol Cell Biol       Date:  2011-09-14       Impact factor: 94.444

8.  Rho kinase regulates neurite outgrowth of hippocampal neurons via calcium dependent cytoskeleton regulation.

Authors:  Zhisheng Ji; Zhenbin Cai; Jifeng Zhang; Nannuan Liu; Jing Chen; Minghui Tan; Hongsheng Lin; Guoqing Guo
Journal:  Am J Transl Res       Date:  2017-02-15       Impact factor: 4.060

9.  Y27632, a Rho-activated kinase inhibitor, normalizes dysregulation in alpha1-adrenergic receptor-induced contraction of Lyon hypertensive rat artery smooth muscle.

Authors:  Maria Regina Freitas; Masumi Eto; Jason A Kirkbride; Christa Schott; Jean Sassard; Jean-Claude Stoclet
Journal:  Fundam Clin Pharmacol       Date:  2009-03-09       Impact factor: 2.748

10.  Calcium-based dendritic excitability and its regulation in the deep cerebellar nuclei.

Authors:  Eve R Schneider; Eugene F Civillico; Samuel S-H Wang
Journal:  J Neurophysiol       Date:  2013-02-20       Impact factor: 2.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.